TRANSTHERA-B Sells Shares at Approximately 18% Discount to Generate HKD190 Million Net Proceeds
Share Placement Announcement: TRANSTHERA-B (02617.HK) announced the placement of 2.1 million shares at HKD92.85 per share, representing a 17.98% discount from the previous closing price of HKD113.2.
Funding Purpose: The placement is expected to raise approximately HKD190 million, with around 60% allocated for the ongoing clinical trial of Tinengotinib for cholangiocarcinoma treatment and further research and development of the product.
Trade with 70% Backtested Accuracy
Analyst Views on 02617
No data
About the author
<Research>SPDBI Identifies Certain H Shares with Increased Market Capitalization at Lock-up Period's Conclusion in the Coming Year (Table)
Stock Performance Overview: Various Hong Kong stocks showed mixed performance, with ZIJIN GOLD INTL and MINIMAX-WP experiencing significant gains, while others like GUMING and CHERY AUTO faced declines.
Short Selling Data: Short selling activity varied across stocks, with FWD showing a high short selling ratio of 16.999%, while NANSHAN AL INTL had a notably low ratio of 0.135%.
Market Capitalization Insights: The market capitalization at the end of the lock-up periods for these stocks ranges from 21.4 billion to 406.6 billion, indicating varying levels of investor interest and company valuations.
Future Lock-up Dates: Key lock-up expiration dates for these stocks are set between early 2026 and late 2026, which may impact trading strategies and stock performance as these dates approach.
HSI Rises 123 Points at Opening; Pharmaceutical Stocks Surge; HAIDILAO Jumps Over 5%
US Stock Market Performance: US stocks fell 398 points (0.8%) following JPMorgan's earnings report, while chip stocks saw increased interest.
Hong Kong Market Opening: The Hong Kong bourse opened higher, with the HSI up 123 points (0.5%) and notable gains in tech stocks like BABA-W and TENCENT.
Inflation Rate in China: China's inflation rate for December was reported at 0.8%, slightly above the previous 0.7% but below the forecast of 0.9%.
Pharmaceutical Sector Activity: Several pharmaceutical stocks, including HANSOH PHARMA and BEONE MEDICINES, opened higher, while PHARMARON anticipated a decrease in full-year profit but still saw a slight increase in stock price.
TRANSTHERA-B Sells Shares at Approximately 18% Discount to Generate HKD190 Million Net Proceeds
Share Placement Announcement: TRANSTHERA-B (02617.HK) announced the placement of 2.1 million shares at HKD92.85 per share, representing a 17.98% discount from the previous closing price of HKD113.2.
Funding Purpose: The placement is expected to raise approximately HKD190 million, with around 60% allocated for the ongoing clinical trial of Tinengotinib for cholangiocarcinoma treatment and further research and development of the product.
TRANSTHERA-B (02617.HK) Drops 17% Amid Increased Trading Volume
Stock Performance: TRANSTHERA-B (02617.HK) opened 1.7% lower and experienced a significant decline, dropping as much as 18.8% to a low of HKD137 before recovering slightly to HKD140, down 17.01%.
Trading Volume: The trading volume reached 2.008 million shares, with a total value of HKD294 million.
Initial Listing: The company was listed on June 23 at an initial price of HKD13.15 per share.
Lock-up Period: The six-month lock-up period for cornerstone investors ends today, which may influence stock trading dynamics.
<Daily Summary> HSI Ends at 25,468, Gaining 233 Points; HSTI Finishes at 5,457, Up 55 Points; CHINA LIFE Surges Over 4%; Market Trading Volume Increases
Market Performance: The Hang Seng Index (HSI) rose by 233 points (0.9%) to close at 25,468, with significant gains also seen in the HSTI and HSCEI, which increased by 55 points (1.0%) and 85 points (1.0%) respectively, and market turnover reached $183.14 billion.
Active Heavyweights: Major stocks like Meituan, Ping An, Tencent, Alibaba, and Xiaomi saw positive movements, with Meituan closing up 1.8% at $101.3 and Tencent up 1.4% at $605, amidst notable short selling activity.
HSI & HSCEI Constituents on Move: China Life and Li Ning experienced substantial gains, with China Life rising 4.3% to $28.56 and Li Ning also up 4.3% to $19.07, reflecting strong investor interest.
Notable Stock Surge: Transthera-B saw a remarkable increase of 17.4%, closing at $171.3, indicating a significant upward trend in its stock performance.
HSI Drops 245 Points as Gold Jewelry Stocks Decline; LAOPU GOLD Falls 8%
Market Performance: The HSI fell by 0.9% to 25,781, with the HSCEI and HSTECH also declining by 0.8% and 1.4%, respectively, amid a total market turnover of $227.536 billion.
Gold Price Decline: Gold prices experienced their largest single-day drop in over a decade, impacting major mining companies like Lingbao Gold and Zijin Mining, which saw significant declines in their stock prices.
Consumer and Pharma Stocks: Consumer stock POP MART rose by 2.4% following a substantial revenue increase, while several pharmaceutical stocks showed mixed results, with some advancing and others declining after rating changes.
Economic Indicators: China's PPI and inflation rates for September showed slight improvements, with PPI at -2.3% and inflation at -0.3%, both better than previous values.
<Research>SPDBI Identifies Certain H Shares with Increased Market Capitalization at Lock-up Period's Conclusion in the Coming Year (Table)
Stock Performance Overview: Various Hong Kong stocks showed mixed performance, with ZIJIN GOLD INTL and MINIMAX-WP experiencing significant gains, while others like GUMING and CHERY AUTO faced declines.
Short Selling Data: Short selling activity varied across stocks, with FWD showing a high short selling ratio of 16.999%, while NANSHAN AL INTL had a notably low ratio of 0.135%.
Market Capitalization Insights: The market capitalization at the end of the lock-up periods for these stocks ranges from 21.4 billion to 406.6 billion, indicating varying levels of investor interest and company valuations.
Future Lock-up Dates: Key lock-up expiration dates for these stocks are set between early 2026 and late 2026, which may impact trading strategies and stock performance as these dates approach.
HSI Rises 123 Points at Opening; Pharmaceutical Stocks Surge; HAIDILAO Jumps Over 5%
US Stock Market Performance: US stocks fell 398 points (0.8%) following JPMorgan's earnings report, while chip stocks saw increased interest.
Hong Kong Market Opening: The Hong Kong bourse opened higher, with the HSI up 123 points (0.5%) and notable gains in tech stocks like BABA-W and TENCENT.
Inflation Rate in China: China's inflation rate for December was reported at 0.8%, slightly above the previous 0.7% but below the forecast of 0.9%.
Pharmaceutical Sector Activity: Several pharmaceutical stocks, including HANSOH PHARMA and BEONE MEDICINES, opened higher, while PHARMARON anticipated a decrease in full-year profit but still saw a slight increase in stock price.
TRANSTHERA-B Sells Shares at Approximately 18% Discount to Generate HKD190 Million Net Proceeds
Share Placement Announcement: TRANSTHERA-B (02617.HK) announced the placement of 2.1 million shares at HKD92.85 per share, representing a 17.98% discount from the previous closing price of HKD113.2.
Funding Purpose: The placement is expected to raise approximately HKD190 million, with around 60% allocated for the ongoing clinical trial of Tinengotinib for cholangiocarcinoma treatment and further research and development of the product.
TRANSTHERA-B (02617.HK) Drops 17% Amid Increased Trading Volume
Stock Performance: TRANSTHERA-B (02617.HK) opened 1.7% lower and experienced a significant decline, dropping as much as 18.8% to a low of HKD137 before recovering slightly to HKD140, down 17.01%.
Trading Volume: The trading volume reached 2.008 million shares, with a total value of HKD294 million.
Initial Listing: The company was listed on June 23 at an initial price of HKD13.15 per share.
Lock-up Period: The six-month lock-up period for cornerstone investors ends today, which may influence stock trading dynamics.
<Daily Summary> HSI Ends at 25,468, Gaining 233 Points; HSTI Finishes at 5,457, Up 55 Points; CHINA LIFE Surges Over 4%; Market Trading Volume Increases
Market Performance: The Hang Seng Index (HSI) rose by 233 points (0.9%) to close at 25,468, with significant gains also seen in the HSTI and HSCEI, which increased by 55 points (1.0%) and 85 points (1.0%) respectively, and market turnover reached $183.14 billion.
Active Heavyweights: Major stocks like Meituan, Ping An, Tencent, Alibaba, and Xiaomi saw positive movements, with Meituan closing up 1.8% at $101.3 and Tencent up 1.4% at $605, amidst notable short selling activity.
HSI & HSCEI Constituents on Move: China Life and Li Ning experienced substantial gains, with China Life rising 4.3% to $28.56 and Li Ning also up 4.3% to $19.07, reflecting strong investor interest.
Notable Stock Surge: Transthera-B saw a remarkable increase of 17.4%, closing at $171.3, indicating a significant upward trend in its stock performance.
HSI Drops 245 Points as Gold Jewelry Stocks Decline; LAOPU GOLD Falls 8%
Market Performance: The HSI fell by 0.9% to 25,781, with the HSCEI and HSTECH also declining by 0.8% and 1.4%, respectively, amid a total market turnover of $227.536 billion.
Gold Price Decline: Gold prices experienced their largest single-day drop in over a decade, impacting major mining companies like Lingbao Gold and Zijin Mining, which saw significant declines in their stock prices.
Consumer and Pharma Stocks: Consumer stock POP MART rose by 2.4% following a substantial revenue increase, while several pharmaceutical stocks showed mixed results, with some advancing and others declining after rating changes.
Economic Indicators: China's PPI and inflation rates for September showed slight improvements, with PPI at -2.3% and inflation at -0.3%, both better than previous values.
